GLSI — Greenwich Lifesciences Share News
0.000.00%
Last trade - 00:00- $235.29m
- $226.42m
U.S. STOCKS ON THE MOVE-Apple, Intel, Alignment Healthcare
U.S. STOCKS ON THE MOVE -Health insurers, Arista, Savara
U.S. STOCKS ON THE MOVE -Virgin Galactic, Humana, Broadcom
Greenwich LifeSciences rises as new data widens potential breast cancer drug market
Brief: Greenwich Lifesciences Provides Update On Patent Claims Potentially Doubling Gp2 Market Potential
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture
U.S. STOCKS ON THE MOVE-Rivian, Biohaven, CervoMed
U.S. STOCKS ON THE MOVE-Alibaba, Accenture, energy companies
Brief: Greenwich Lifesciences Inc - Initiates New Us Clinical Sites For Flamingo-01 Phase Iii Trial
Greenwich LifeSciences rises after expanding late‑stage breast cancer trial
Brief: Greenwich Lifesciences Provides Update On Upcoming Aacr Meeting
U.S. STOCKS ON THE MOVE -Steel Dynamics, Aldeyra, Cencora
U.S. STOCKS ON THE MOVE-Qualcomm, Canadian Solar, Draftkings
U.S. STOCKS ON THE MOVE-Elbit Systems, Oklo, Janus Henderson
U.S. STOCKS ON THE MOVE-Uber, Honeywell, Delta
Brief: Greenwich Lifesciences Provides Update Showing Continued Reduction In Recurrence Rate In The Open Label Arm Of Flamingo-01
Greenwich LifeSciences rises as trial shows lower breast cancer return rate
Brief: Greenwich Lifesciences Provides Update On Flamingo-01 Cash Burn Rate And Financing Strategy